Abstract:
A means for determining the effectiveness of interferon therapy in individuals who are infected with Hepatitis C Virus (HCV) and are receiving such therapy. Monitoring the level of anti-HCV IgM and/or anti-GOR IgG provide means for establishing whether or not the infected patient is responding to interferon therapy; such monitoring is especially useful for patients diagnosed with chronic acute HCV infections.
Abstract:
A means for determining the effectiveness of interferon therapy in individuals who are infected with Hepatitis C Virus (HCV) and are receiving such therapy. Monitoring the level of anti-HCV IgM and/or anti-GOR IgG provide means for establishing whether or not the infected patient is responding to interferon therapy; such monitoring is especially useful for patients diagnosed with chronic acute HCV infections.
Abstract:
A means for determining the effectiveness of interferon therapy for individuals receiving such therapy for HCV infections. Assaying for the presence of anti-HCV IgG and anti-HCV IgM and determining a ratio of the pre-interferon therapy amount of anti-HCV IgG to the pre-interferon therapy amount of anti-HCV IgM provide means for indicating the likelihood of an individual's response to interferon therapy.
Abstract:
A means for determining the effectiveness of interferon therapy for individuals receiving such therapy for HCV infections. Assaying for the presence of anti-HCV IgG and anti-HCV IgM and determining a ratio of the pre-interferon therapy amount of anti-HCV IgG to the pre-interferon therapy amount of anti-HCV IgM provide means for indicating the likelihood of an individual's response to interferon therapy.